Concepedia

F.J.S.M. Cruz

FC

Statistics

Publications

2

Citations

76

H-Index

2

Active since

2023

Affiliations

The Maria Sklodowska-Curie National Research Institute of Oncology(Current)

F.J.S.M. Cruz is an author at The Maria Sklodowska-Curie National Research Institute of Oncology specializing in medicine, gastric diseases, and pharmacology.

Publications per year

2023–2023

2

Publications

2

VP1-2023: Pembrolizumab (pembro) plus chemotherapy (chemo) as first-line therapy for advanced HER2-negative gastric or gastroesophageal junction (G/GEJ) cancer: Phase III KEYNOTE-859 study

Sun Young Rha, L.S. Wyrwicz, P.E. Yanez Weber et al. · Annals of Oncology · 2023 · 66 citations · Full text

, , +13

613P Effect of prior use of anti-VEGF agents on overall survival in patients with refractory metastatic colorectal cancer: A post-hoc analysis of the phase III SUNLIGHT trial

Gerald W. Prager, Marwan Fakih, Fortunato Ciardiello et al. · Annals of Oncology · 2023 · 10 citations · Full text

, , +17

1–2 of 2